Press releases

2026-07-06 14:20 Lipum Announces Peer-Reviewed Publication of Positive First-in-Human Phase I Results for SOL-116
Lipum today announced that results from the First-in-Human (FIH) Phase I trial of its drug candidate SOL-116 have been published in the peer-reviewed journal...
2026-07-02 10:35 Lipum secures an EUR 8 million Horizon Europe grant
Lipum has signed the grant agreement for BEYOND, a project selected by Horizon Europe under the call “Boosting the translation of biotech research...
2026-03-20 11:00 The merger between Flerie and Lipum has been completed Regulatory
THIS ANNOUNCEMENT SHOULD NOT BE DISTRIBUTED, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR THE UNITED...
2026-03-12 12:30 The Swedish Companies Registration Office has granted permission to implement the merger plan between Flerie and Lipum Regulatory
THIS ANNOUNCEMENT SHOULD NOT BE DISTRIBUTED, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR THE UNITED...
2026-03-10 08:14 Lipum selected for Horizon Europe grant Regulatory MAR
Lipum announces that the company is leading a consortium that has been selected, pending final negotiations, for an EUR 8 million grant from the Horizon...
2026-02-25 08:00 Lipum AB – Year-end report 2025 Regulatory
Lipum AB (publ) has published the Q4 interim and year-end report for 2025. Below is a summary, a complete report (only in Swedish) is available on the...
2025-11-27 08:00 Lipum AB – interim report Q3 for the period July-September 2025 Regulatory
Lipum AB (publ) has published the interim report Q3 for the period July-September 2025. Below is a summary, a complete report (only in Swedish) is available...
2025-11-18 08:02 STATEMENT BY THE BOARD OF DIRECTORS OF LIPUM IN VIEW OF THE MERGER OFFER BY FLERIE Regulatory
The Board of Directors of Lipum AB (publ) (“Lipum”) unanimously recommends the shareholders of Lipum to vote in favour of the completion of...
2025-11-18 08:00 Flerie and Lipum have agreed on a merger plan Regulatory MAR
THIS ANNOUNCEMENT SHOULD NOT BE DISTRIBUTED, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR THE UNITED...
2025-10-30 08:30 Lipum presents new topline data supporting BSSL’s role in rheumatoid arthritis
Lipum AB (publ) today announced topline results from collaborative studies with Senior Associate Professor Alf Kastbom and team at Linköping University...
Next

Media